Cannabis Rescheduled to Schedule III by U.S. Federal Government on April 23, 2026
On April 23, 2026, Jushi Holdings Inc. issued a statement acknowledging the decision by the U.S. federal government to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act. The move marks a significant shift in federal policy regarding cannabis regulation and classification.
The reclassification of cannabis to Schedule III reflects its recognition as having medical value while still maintaining certain restrictions due to potential risks. Under this new designation, cannabis will no longer be classified alongside substances deemed to have no accepted medical use and a high potential for abuse, such as heroin and LSD. Instead, it will join other Schedule III substances that are considered to have moderate or low potential for physical and psychological dependence, such as anabolic steroids and ketamine.
This change is expected to impact various aspects of the cannabis industry, including taxation policies, research opportunities, and banking access. Businesses operating within the sector may experience reduced barriers in areas like financial services and scientific studies aimed at exploring therapeutic applications of cannabis. Additionally, healthcare providers could see expanded options for prescribing treatments involving cannabis-based products.
The announcement follows years of advocacy from industry stakeholders and policymakers seeking reform in how cannabis is regulated at the federal level. While individual states have implemented varying degrees of legalization or decriminalization measures over recent decades, this federal action represents a notable development in aligning national policy with evolving public attitudes toward cannabis use.
Further details on implementation timelines or additional regulatory adjustments stemming from this rescheduling decision were not disclosed at the time of reporting.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 23, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]






